A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19127265

Br. J. Cancer 2009 Jan 13 100 1 28-36

Download in:

View as

Triples

General Info

PMID
19127265